InsidersTradesSigma
Follow the 리브스메드 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 리브스메드 has logged 21 public disclosures. Market capitalisation: €1,009.5bn. The latest transaction was reported on 22 April 2026 (Purchase). Among the most active insiders: 스톤브릿지벤처스. Every trade is accessible without an account.
21
Insider Decl.
n/a
Thresholds
n/a
14 ops.
Buy Volume
n/a
6 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 April 2026
Declarations21 total
1,465,662 sharesKRXDART:20260407003261
21 of 21 declarations
About 리브스메드
리브스메드 operates in the healthcare and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative solutions for healthcare.